Using siRNA-mediated knockdown of PRDM3 in PK-8 pancreatic cancer cells, Tanaka and colleagues also showed that PRDM3 promotes pancreatic cancer cell proliferation and migration through the inhibition of a KRAS suppressor miR-9614. The gene discussed is MECOM; the disease is pancreatic neoplasm.